1558.HK

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. 1558.HK

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 1558.HK 6600.HK 0503.HK 6606.HK 6667.HK 6819.HK 0708.HK 8405.HK 0286.HK 9906.HK
6M 63.04 % 64.21 % 13.29 % -20.56 % -6.74 % 9.73 % -41.38 % 13.11 % -13.82 % 3.90 %
YTD 71.68 % 31.09 % 23.58 % -37.57 % -30.77 % 12.78 % -18.27 % 4.55 % -22.49 % -23.08 %
1Y 55.69 % 88.90 % 23.58 % -47.14 % -23.73 % -17.98 % -26.09 % 7.81 % -31.41 % -32.20 %
3Y 207.16 % 31.09 % 12.34 % -79.30 % -60.00 % -46.30 % -94.69 % -17.86 % -92.13 % -25.58 %
5Y 42.29 % -0.43 % 103.70 % -83.17 % -60.00 % -40.29 % -97.02 % -22.47 % -90.78 % -14.44 %
10Y 118.43 % -0.43 % -37.16 % -83.17 % -60.00 % -22.07 % -76.87 % -21.59 % -93.37 % -33.88 %
From the beginning 118.43 % -0.43 % -59.35 % -83.17 % -60.00 % -22.07 % 14.86 % -21.59 % 2.34 % -33.88 %

Dividend

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

SciClone Pharmaceuticals (Holdings) Limited

Lansen Pharmaceutical Holdings Limited

IntelliCentrics Global Holdings Ltd.

China Evergrande New Energy Vehicle Group Limited

Hang Chi Holdings Limited

Aidigong Maternal & Child Health Limited